Communiqués Yabao Pharmaceutical Group Co., Ltd

Actions

Cours en clôture Shanghai S.E. 09/10/2026			Varia. 5j.	Varia. 1 janv.
7,070 ^CNY	+3,67 %		+3,67 %	+8,94 %

31/07	Yabao Pharmaceutical Group Co., Ltd publie ses résultats pour le premier semestre clos le 30 juin 2026	CI
31/07	Yabao Pharmaceutical Group Co., Ltd (SHSE:600351) annonce un rachat d'actions pour un montant de 200 millions CNY.	CI

30/06/16	Yabao Pharmaceutical : Pharmaceuticals and LFB Biomedicaments Enter Into Strategic Partnership to Deliver VIALEBEX® (LFB’s Human Albumin) in China	BU
20/04/16	Yabao Pharmaceutical : Pharmaceuticals and Salus Pharma Announce Strategic Partnership for Generic Drugs	BU
12/01/16	Yabao Pharmaceuticals : and Sciecure Pharma Announce Strategic Partnership to Co-develop, Manufacture and Commercialize Generics for U.S. and China	BU
20/10/15	Yabao Pharmaceuticals : Enters Second Innovative Collaboration With Eli Lilly and Company to Develop Diabetes Treatment	BU
15/09/15	Yabao Pharmaceuticals : and Primary Peptides Announce Exclusive China Partnership	BU
07/09/15	Yabao Pharmaceuticals : and University of South Australia Announce New Joint Drug Discovery Laboratory	BU